Sun Pharma Advanced Research Company Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SPARC has submitted a routine compliance certificate to the stock exchanges for the quarter ended June 30, 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime), on July 5, 2025 and filed with the exchanges on July 14, 2025. It confirms that all share certificates received for dematerialization during the quarter were processed (accepted or rejected) within the required timelines, the physical certificates were mutilated and cancelled, and the depository's name was updated as the registered owner in the company's records. The RTA also noted that no requests for rematerialization of shares were received during the quarter.
This is a standard regulatory compliance filing with no material impact on the business, operations, or stock price. It simply confirms that SPARC's share dematerialization processes are running smoothly and in line with SEBI rules.